Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Neuronal activity in vivo enhances functional myelin repair
Fernando C. Ortiz, … , Brahim Nait Oumesmar, María Cecilia Angulo
Fernando C. Ortiz, … , Brahim Nait Oumesmar, María Cecilia Angulo
Published March 21, 2019
Citation Information: JCI Insight. 2019;4(9):e123434. https://doi.org/10.1172/jci.insight.123434.
View: Text | PDF
Research Article Neuroscience

Neuronal activity in vivo enhances functional myelin repair

  • Text
  • PDF
Abstract

In demyelinating diseases, such as multiple sclerosis, demyelination of neuronal fibers impairs impulse conduction and causes axon degeneration. Although neuronal activity stimulates oligodendrocyte production and myelination in normal conditions, it remains unclear whether the activity of demyelinated axons restores their loss of function in a harmful environment. To investigate this question, we established a model to induce a moderate optogenetic stimulation of demyelinated axons in the corpus callosum at the level of the motor cortex in which cortical circuit activation and locomotor effects were reduced in adult freely moving mice. We demonstrate that a moderate activation of demyelinated axons enhances the differentiation of oligodendrocyte precursor cells onto mature oligodendrocytes but only under a repeated stimulation paradigm. This activity-dependent increase in the oligodendrocyte pool promotes an extensive remyelination and functional restoration of conduction, as revealed by ultrastructural analyses and compound action potential recordings. Our findings reveal the need for preserving an appropriate neuronal activity in the damaged tissue to promote oligodendrocyte differentiation and remyelination, likely by enhancing axon-oligodendroglia interactions. Our results provide new perspectives for translational research using neuromodulation in demyelinating diseases.

Authors

Fernando C. Ortiz, Chloé Habermacher, Mariana Graciarena, Pierre-Yves Houry, Akiko Nishiyama, Brahim Nait Oumesmar, María Cecilia Angulo

×

Figure 3

Repeated photostimulation in vivo is required to maintain OPC differentiation in demyelinated lesions.

Options: View larger image (or click on image) Download as PowerPoint
Repeated photostimulation in vivo is required to maintain OPC differenti...
(A) Experimental design with a single and repeated photostimulation paradigm during a week. (B) Olig2 (shown in green) and CC1 (shown in red) cells stained at 14 dpi in control LPC-induced lesions (control), after a single photostimulation session at 7 dpi (single) and after 7 photostimulation sessions over a week (repeated). Mature Olig2+CC1+ OLs are indicated (white arrowheads). Note that colors are pseudocolors and correspond to Alexa Fluor 405 (405-nm excitation) for Olig2 and Alexa Fluor 633 (633-nm excitation) for CC1. Scale bar: 25 μm. (C) Density of Olig2+CC1– OPCs (top) and Olig2+CC1+ OLs (bottom) in the 3 conditions at 14 dpi (n = 8, n = 9, and n = 8 lesions for control, single, and repeated protocols, respectively; Kruskal-Wallis statistics = 3.69 and 11.48 for Olig2+CC1– and Olig2+CC1+ cells, respectively; Kruskal-Wallis test followed by Bonferroni’s multiple comparison). Data shown as mean ±SEM.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts